Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Harumi Ogawa is active.

Publication


Featured researches published by Harumi Ogawa.


Bioorganic & Medicinal Chemistry | 2002

Halohydrin and oxime derivatives of radicicol: synthesis and antitumor activities.

Tsutomu Agatsuma; Harumi Ogawa; Kazuhito Akasaka; Akira Asai; Yoshinori Yamashita; Tamio Mizukami; Shiro Akinaga; Yutaka Saitoh

Novel halohydrin and oxime derivatives of radicicol (1) were prepared and evaluated for their v-src tyrosine kinase inhibitory, antiproliferative, and antitumor activities. Some of the resulting derivatives showed significantly improved antitumor activities than those of 1 in vitro as tested in a cell proliferation assay and in vivo using sc-inoculated human breast carcinoma and epidermoid tumor models. Design and synthesis of radicicol-based novel affinity probes are also described.


Organic Letters | 2002

UCS1025A and B, New Antitumor Antibiotics from the Fungus Acremonium Species

Tsutomu Agatsuma; Tsutomu Akama; Shinji Nara; Shigeki Matsumiya; Ryuichiro Nakai; Harumi Ogawa; Shizuo Otaki; Shun-ichi Ikeda; Yutaka Saitoh; Yutaka Kanda


Journal of Medicinal Chemistry | 2003

Synthesis and antitumor activity of novel O-carbamoylmethyloxime derivatives of radicicol.

Yoji Ikuina; Nobuyoshi Amishiro; Mayumi Miyata; Hiroaki Narumi; Harumi Ogawa; Tadakazu Akiyama; Yukimasa Shiotsu; Shiro Akinaga; Chikara Murakata


The Journal of Antibiotics | 2000

UCS1025A, a Novel Antibiotic Produced by Acremonium sp.

Ryuichiro Nakai; Harumi Ogawa; Akira Asai; Katsuhiko Ando; Tsutomu Agaisuma; Shigeki Maisumiya; Shiro Akinaga; Yoshinori Yamashita; Tamio Mizukami


Chemistry & Biology | 2006

Telomerase Inhibitors Identified by a Forward Chemical Genetics Approach Using a Yeast Strain with Shortened Telomere Length

Ryuichiro Nakai; Hiroyuki Ishida; Akira Asai; Harumi Ogawa; Yoshihiro Yamamoto; Hideki Kawasaki; Shiro Akinaga; Tamio Mizukami; Yoshinori Yamashita


The Journal of Antibiotics | 1998

UCH9, a New Antitumor Antibiotic Produced by Streptomyces: I. Producing Organism, Fermentation, Isolation and Biological Activities

Harumi Ogawa; Yoshinori Yamashita; Ritsuko Katahira; Shigeru Chiba; Toshiaki Iwasaki; Tadashi Ashizawa; Hirofumi Nakano


Nucleic Acids Research | 1998

Solution structure of the novel antitumor drug UCH9 complexed with d(TTGGCCAA)2 as determined by NMR

Ritsuko Katahira; Masato Katahira; Yoshinori Yamashita; Harumi Ogawa; Yoshimasa Kyogoku; Mayumi Yoshida


The Journal of Antibiotics | 1998

UCH9, a New Antitumor Antibiotic Produced by Streptomyces II. Structure Elucidation of UCH9 by Mass and NMR Spectroscopy

Ritsuko Katahira; Yoichi Uosaki; Harumi Ogawa; Yoshinori Yamashita; Hirofumi Nakano; Mayumi Yoshida


The Journal of Antibiotics | 2000

Pyrronamycin A and B, Novel Antitumor Antibiotics Containing Pyrrole-amide Repeating Unit, Produced by Streptomyces sp.

Akira Asai; Yasushi Sakai; Harumi Ogawa; Yoshinori Yamashita; Shingo Kakita; Keiko Ochiai; Tadashi Ashizawa; Akira Mihara; Tamio Mizukami; Hirofumi Nakano


Archive | 1997

DERIVADOS DE RADICICOL.

Shiro Akinaga; Tadakazu Akiyama; Nobuyoshi Amishiro; Yoji Ino; Mayumi Miyata; Chikara Murakata; Harumi Ogawa; Yukimasa Shiotsu; Shiroh Soga

Collaboration


Dive into the Harumi Ogawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shiro Akinaga

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Akira Asai

University of Shizuoka

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tamio Mizukami

Nagahama Institute of Bio-Science and Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge